Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone

被引:0
|
作者
M. Alberghini
K. Kliskey
T. Krenacs
P. Picci
L. Kindblom
R. Forsyth
N. A. Athanasou
机构
[1] Istituto Ortopedico Rizzoli,Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
[2] University of Oxford,1st Department of Pathology and Experimental Cancer Research
[3] Semmelweis University,undefined
[4] Royal Orthopaedic Hospital,undefined
[5] N. Goormaghtigh Institute of Pathology,undefined
来源
Virchows Archiv | 2010年 / 456卷
关键词
Giant cell; Bone tumour; Osteoclast; Metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
Giant cell tumour of bone (GCTB) is a primary tumour of bone that may rarely, in the absence of malignant cytological features, produce metastatic lesions, most commonly in the lungs. Whether these lung nodules represent true neoplastic secondaries or implants derived from the primary tumour is not certain. In this study, we have analysed the morphological and immunophenotypic features of 19 conventional GCTBs and corresponding lung nodules for expression of macrophage, osteoclast, proliferation and tumour-associated markers. A striking morphological feature of all GCTBs that produced lung secondaries was the presence of large areas of haemorrhage and thrombus formation; mononuclear and multinucleated cells of GCTB were frequently found within these areas of haemorrhage and thrombus. A similar pattern of CD14, CD33, HLA-DR and CD51 expression was seen in macrophages and giant cells in primary and secondary tumours. Smooth muscle actin expression was frequently noted in primary GCTBs that recurred and metastasised. No difference was seen in the expression of p53, p63, Ki-67, cyclin D1 or Bcl-2 in primary and secondary tumours. Our findings suggest that most lung nodules associated with primary conventional GCTBs are implants derived from tumour emboli formed in areas of haemorrhage and thrombus formation within the primary tumour.
引用
收藏
页码:97 / 103
页数:6
相关论文
共 50 条
  • [41] Metachronous multicentric giant cell tumour of bone
    Navatha Vangala
    Shantveer G. Uppin
    Sobiya Mehnaz Ayesha
    K. R. Harshavardhana
    P. Chandrasekhar
    Skeletal Radiology, 2018, 47 : 1559 - 1566
  • [42] Treatment of giant-cell tumour of bone
    不详
    BRITISH MEDICAL JOURNAL, 1937, 1937 : 554 - 554
  • [43] PRIMARY CUTANEOUS HODGKINS-DISEASE - UNIQUE CLINICAL, MORPHOLOGICAL AND IMMUNOPHENOTYPIC FEATURES
    SLOUTOS, N
    KADIN, ME
    LABORATORY INVESTIGATION, 1991, 64 (01) : A30 - A30
  • [44] SYNTHETIC BONE SUBSTITUTES IN THE TREATMENT OF GIANT CELL TUMOUR OF BONE
    Patrikov, Kircho
    Slavchev, Svetoslav A.
    Georgiev, Georgi P.
    Hristov, Boyan
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2020, 73 (06): : 872 - 877
  • [45] Differentiation of giant cell tumours of bone, primary aneurysmal bone cysts, and aneurysmal bone cysts secondary to giant cell tumour of bone: using whole-tumour CT texture analysis parameters as quantitative biomarkers
    Wang, J. -Y
    Sun, D.
    Liu, C. -Y.
    Hou, B. -W.
    Li, Y. -T.
    Hu, S.
    Zhang, Y.
    Morelli, J. N.
    Li, X. -M.
    CLINICAL RADIOLOGY, 2023, 78 (07) : 532 - 539
  • [46] Serum acid phosphatase as a tumour marker in giant cell tumour of bone
    Goto, T
    Iijima, T
    Kawano, H
    Yamamoto, A
    Arai, M
    Matsuda, K
    Yokokura, S
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2001, 121 (07) : 411 - 413
  • [47] Serum acid phosphatase as a tumour marker in giant cell tumour of bone
    T. Goto
    T. Iijima
    H. Kawano
    A. Yamamoto
    M. Arai
    K. Matsuda
    S. Yokokura
    Archives of Orthopaedic and Trauma Surgery, 2001, 121 : 411 - 413
  • [48] Clinical, radiological and pathological outcomes following treatment of primary giant cell tumour of bone with Denosumab
    Murphy, Benjamin
    Vodanovich, Domagoj
    Spelman, Tim
    Gullifer, James
    Slavin, John
    Powell, Gerard
    Pang, Grant
    Choong, Peter
    ANZ JOURNAL OF SURGERY, 2020, 90 (12) : 2553 - 2558
  • [49] Recurrence of a primary malignant giant cell tumour of bone 14 years after initial surgery
    Merad, M
    Mesurolle, B
    Guinebretière, JM
    Lecesne, A
    Missenard, G
    Vanel, D
    EUROPEAN RADIOLOGY, 2001, 11 (08) : 1483 - 1486
  • [50] Recurrence of a primary malignant giant cell tumour of bone 14 years after initial surgery
    Myriam Merad
    Benoît Mesurolle
    Jean-Marc Guinebretière
    Axel Lecesne
    Gilles Missenard
    Daniel Vanel
    European Radiology, 2001, 11 : 1483 - 1486